Glutamate Signaling and Drug Abuse

谷氨酸信号传导和药物滥用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The abuse of the amphetamine-like psychostimulants is a medical and social problem throughout the world. The rewarding properties of these drugs are linked to their capacity to increase extracellular concentration of dopamine in the forebrain, notably in the nucleus accumbens. The dopaminergic neurons that innervate nucleus accumbens originate in the ventral tegmental area which has been shown to play a critical role in development of chronic drug effects. Despite the advances in our understanding of cellular and molecular actions of these drugs, effective pharmacological treatments for amphetamine and cocaine addiction remain elusive. More recently, a number of investigations have shown that in addition to dopaminergic role in psychostimulant effects, excitatory neurotransmission also plays a very critical role. Glutamate is the major excitatory neurotransmitter in the brain and both nucleus accumbens and ventral tegmental area receive a major glutamatergic innervation from prefrontal cortex. These studies suggest that drugs acting on excitatory neurotransmission may be effective therapeutic agents for treating psychostimulant abuse. The data presented in this proposal suggest that the recently discovered proteins that bind to glutamate receptors can alter glutamatergic transmission and may play an important role in long lasting neuroadaptations after repeated drug exposure. The Homer family of proteins is one of the glutamate receptor binding proteins that bind specifically to metabotropic glutamate receptors. The expression of these proteins in nucleus accumbens is altered after repeated cocaine exposure. Moreover, reducing the level of these proteins in NA during repeated exposure to cocaine prevents the development of behavioral sensitization. Based on these results and others in literature a series of experiments are proposed to study the functional role of these scaffolding proteins in excitatory transmission in nucleus accumbens and their role in drug induced synaptic plasticity.
描述(由申请人提供):苯丙胺类药物滥用 精神兴奋剂是一个世界性的医学和社会问题。的 这些药物的奖励特性与它们增加 细胞外浓度的多巴胺在前脑,特别是在 丘脑核支配延髓核的多巴胺能神经元 起源于腹侧被盖区,该区域已被证明对大脑皮层的活动起着关键作用。 在慢性药物效应发展中的作用。尽管我们的技术进步了, 了解这些药物的细胞和分子作用,有效 安非他明和可卡因成瘾的药物治疗仍然存在 难以捉摸。最近,一些调查显示,除 多巴胺能神经兴奋作用,兴奋性神经传递 也起着非常关键的作用。谷氨酸是主要的兴奋性物质 脑内及中脑核和腹侧被盖的神经递质 该区域接受来自前额皮质的主要脑电能神经支配。这些 研究表明,作用于兴奋性神经传递的药物可能 用于治疗精神兴奋剂滥用的有效治疗剂。数据 这一建议表明,最近发现的蛋白质, 与谷氨酸受体结合可以改变谷氨酸能传递, 在反复用药后持久的神经适应中起重要作用 exposure. Homer家族蛋白是谷氨酸受体结合蛋白之一, 与代谢型谷氨酸受体特异性结合的蛋白质。的 这些蛋白质在丘脑核中的表达在反复的 可卡因暴露此外,降低NA中这些蛋白质的水平, 反复接触可卡因会阻止行为性 致敏基于这些结果和文献中的其他结果, 提出实验来研究这些支架的功能作用 伏隔核兴奋性传递中的蛋白质及其在药物中的作用 诱发突触可塑性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MOHAMMADHOSSEIN BEHNAM GHASEMZADEH其他文献

MOHAMMADHOSSEIN BEHNAM GHASEMZADEH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MOHAMMADHOSSEIN BEHNAM GHASEMZADEH', 18)}}的其他基金

KNCQ Potassium Channels and Schizophrenia
KNCQ 钾通道和精神分裂症
  • 批准号:
    8925922
  • 财政年份:
    2014
  • 资助金额:
    $ 7.44万
  • 项目类别:
KNCQ Potassium Channels and Schizophrenia
KNCQ 钾通道和精神分裂症
  • 批准号:
    8824412
  • 财政年份:
    2014
  • 资助金额:
    $ 7.44万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    6687845
  • 财政年份:
    2002
  • 资助金额:
    $ 7.44万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    6868951
  • 财政年份:
    2002
  • 资助金额:
    $ 7.44万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    6624092
  • 财政年份:
    2002
  • 资助金额:
    $ 7.44万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    7022914
  • 财政年份:
    2002
  • 资助金额:
    $ 7.44万
  • 项目类别:
Glutamate Signaling and Drug Abuse
谷氨酸信号传导和药物滥用
  • 批准号:
    7190541
  • 财政年份:
    2002
  • 资助金额:
    $ 7.44万
  • 项目类别:
GLUTAMATE RECEPTOR AND CHRONIC COCAINE
谷氨酸受体和慢性可卡因
  • 批准号:
    6129490
  • 财政年份:
    1999
  • 资助金额:
    $ 7.44万
  • 项目类别:
GLUTAMATE RECEPTOR AND CHRONIC COCAINE
谷氨酸受体和慢性可卡因
  • 批准号:
    6174713
  • 财政年份:
    1999
  • 资助金额:
    $ 7.44万
  • 项目类别:

相似海外基金

Identifying the causal role of the amygdala in human approach-avoidance conflict behavior test
确定杏仁核在人类接近-回避冲突行为测试中的因果作用
  • 批准号:
    10516014
  • 财政年份:
    2021
  • 资助金额:
    $ 7.44万
  • 项目类别:
Identifying the causal role of the amygdala in human approach-avoidance conflict behavior test
确定杏仁核在人类接近-回避冲突行为测试中的因果作用
  • 批准号:
    10549552
  • 财政年份:
    2021
  • 资助金额:
    $ 7.44万
  • 项目类别:
Context Effects of Mobile Consumer Behavior: Test of Affect and Regulatory Focus Theory in Shopping and Investment Decisions
移动消费者行为的情境效应:购物和投资决策中的影响和监管焦点理论检验
  • 批准号:
    414986791
  • 财政年份:
  • 资助金额:
    $ 7.44万
  • 项目类别:
    Research Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了